27.500
−1,08%
2026-10-14
Fundamental Analysis
85 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +81.4% | +46.5% | 3 / 3 | +20.0% | +2.75 pp | +14.71 pp | +17.0% | 0.09 | 9.10 | 63,3 | +20,0% | 27,5 | +81,4% | 9.10 | 10.36 | −12,2% |
| Pts | 12 | 12 | 12 | 12 | 8 | 12 | 4 | 12 | 8 | |||||||
Valuation annotation:Price: 27.500 (close price on 2026-10-14)EPS (TTM): 3.022
Financial charts
1.Revenue & growth
VND bn63,3Q2/26
1.Revenue & growth
VND bn63,3Q2/26
2.Profit & growth
VND bn31,8Q2/26
3.Profit mix (Penman)
VND bn113Q2/26
4.Margins & cost structure
%67.7%Q2/26
5.Returns & cash cycle
% · days29.8%Q2/26
6.Earnings quality & cash
VND bn77,5Q2/26
7.Asset structure
VND bn662Q2/26
8.Funding & debt health
VND bn · times662Q2/26
9.Revenue backlog
VND bn0,24Q2/26
10.Valuation
times · %8,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.101Q2/26
Adjusted EPS growth, latest quarter
110%
Average adjusted EPS growth, 3 quarters
56.0%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26